Literature DB >> 12619088

Remyelination by transplanted olfactory ensheathing cells.

Robin J M Franklin1.   

Abstract

The olfactory ensheathing cells (OECs) of the peripheral olfactory system associate with the axons of the first cranial nerve. These axons are not myelinated by OECs because of their very small diameter. However, when OECs are transplanted into areas where they encounter larger-diameter axons, such as in a model of primary demyelination, these cells assume a myelinating phenotype. Myelinating OECs very closely resemble myelinating Schwann cells by all criteria currently examined, including morphology, ultrastructure, biochemistry, and transcriptional regulation. Indeed, it is currently impossible to reliably distinguish myelinating OECs and myelinating Schwann cells that have been transplanted into experimental models of CNS demyelination. This article describes recent studies on the myelinating properties of transplanted OECs, focusing on their intrinsic myelinating potential and how this can be augmented by the presence of meningeal cells. The relative merits of OECs compared with Schwann cells when transplanted into astrocyte-containing lesions in the CNS are discussed together with their potential role in transplanted-mediated repair of demyelinating disease such as multiple sclerosis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12619088     DOI: 10.1002/ar.b.10013

Source DB:  PubMed          Journal:  Anat Rec B New Anat        ISSN: 1552-4906


  9 in total

Review 1.  Molecular targets in spinal cord injury.

Authors:  Stefan Klussmann; Ana Martin-Villalba
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

Review 2.  Cellular transplantation strategies for spinal cord injury and translational neurobiology.

Authors:  Paul J Reier
Journal:  NeuroRx       Date:  2004-10

Review 3.  Thymosin β4 for the treatment of acute stroke: neurorestorative or neuroprotective?

Authors:  Daniel C Morris; Zheng G Zhang; Michael Chopp
Journal:  Expert Opin Biol Ther       Date:  2018-07       Impact factor: 4.388

Review 4.  Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury.

Authors:  Jeffery D Kocsis; Karen L Lankford; Masanori Sasaki; Christine Radtke
Journal:  Neurosci Lett       Date:  2009-01-17       Impact factor: 3.046

5.  Phenotypic Modulation and Neuroprotective Effects of Olfactory Ensheathing Cells: a Promising Tool for Cell Therapy.

Authors:  Rosalia Pellitteri; Lidia Cova; Damiano Zaccheo; Vincenzo Silani; Patrizia Bossolasco
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

6.  Neural crest origin of olfactory ensheathing glia.

Authors:  Perrine Barraud; Anastasia A Seferiadis; Luke D Tyson; Maarten F Zwart; Heather L Szabo-Rogers; Christiana Ruhrberg; Karen J Liu; Clare V H Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 7.  Cellular therapies for treating pain associated with spinal cord injury.

Authors:  Lawrence Leung
Journal:  J Transl Med       Date:  2012-03-06       Impact factor: 5.531

8.  Transplantation of canine olfactory ensheathing cells producing chondroitinase ABC promotes chondroitin sulphate proteoglycan digestion and axonal sprouting following spinal cord injury.

Authors:  Darren Carwardine; Jonathan Prager; Jacob Neeves; Elizabeth M Muir; James Uney; Nicolas Granger; Liang-Fong Wong
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

9.  Insights into olfactory ensheathing cell development from a laser-microdissection and transcriptome-profiling approach.

Authors:  Surangi N Perera; Ruth M Williams; Rachel Lyne; Oliver Stubbs; Dennis P Buehler; Tatjana Sauka-Spengler; Masaharu Noda; Gos Micklem; E Michelle Southard-Smith; Clare V H Baker
Journal:  Glia       Date:  2020-08-28       Impact factor: 8.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.